Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

T Okazaki, Y Tanaka, R Nishio, T Mitsuiye… - Nature medicine, 2003 - nature.com
T Okazaki, Y Tanaka, R Nishio, T Mitsuiye, A Mizoguchi, J Wang, M Ishida, H Hiai…
Nature medicine, 2003nature.com
We recently reported that mice deficient in the programmed cell death-1 (PD-1)
immunoinhibitory coreceptor develop autoimmune dilated cardiomyopathy (DCM), with
production of high-titer autoantibodies against a heart-specific, 30-kDa protein. In this study,
we purified the 30-kDa protein from heart extract and identified it as cardiac troponin I (cTnI),
encoded by a gene in which mutations can cause familial hypertrophic cardiomyopathy
(HCM). Administration of monoclonal antibodies to cTnI induced dilatation and dysfunction …
Abstract
We recently reported that mice deficient in the programmed cell death-1 (PD-1) immunoinhibitory coreceptor develop autoimmune dilated cardiomyopathy (DCM), with production of high-titer autoantibodies against a heart-specific, 30-kDa protein. In this study, we purified the 30-kDa protein from heart extract and identified it as cardiac troponin I (cTnI), encoded by a gene in which mutations can cause familial hypertrophic cardiomyopathy (HCM). Administration of monoclonal antibodies to cTnI induced dilatation and dysfunction of hearts in wild-type mice. Monoclonal antibodies to cTnI stained the surface of cardiomyocytes and augmented the voltage-dependent L-type Ca2+ current of normal cardiomyocytes. These findings suggest that antibodies to cTnI induce heart dysfunction and dilatation by chronic stimulation of Ca2+ influx in cardiomyocytes.
nature.com